<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02672371</url>
  </required_header>
  <id_info>
    <org_study_id>2015P002574</org_study_id>
    <nct_id>NCT02672371</nct_id>
  </id_info>
  <brief_title>The Effects of Sensory Training On Pain Modulation, Cognition and Time to Fatigue in Healthy Adults</brief_title>
  <official_title>The Effects of Sensory Training On Pain Modulation, Cognition and Time to Fatigue in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spaulding Rehabilitation Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomized clinical trial that is assessing the effects of sensory training on
      pain modulation, cognition, and physical endurance (time to fatigue) in healthy participants
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study was not approved for the IRB; we then had no funds to reapply
  </why_stopped>
  <start_date type="Anticipated">June 2017</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PPT</measure>
    <time_frame>Between Visit 2 and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Pain threshold as measured by Pressure Pain Threshold (PPT) between Visits 2 and 3 (active stimulation and sham, order randomized).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DNIC</measure>
    <time_frame>Between Visit 2 and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Pain threshold as measured by Descending Noxious Inhibitory Control (DNIC) between Visits 2 and 3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>VAS</measure>
    <time_frame>Between Visit 2 and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Pain threshold as measured by Visual Analogue Scale (VAS) between Visits 2 and 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EEG</measure>
    <time_frame>Visit 2 and Vist 3...where Visit 1 = baseline, Visit 2 = stimulation visit, sham or active (about 2 days from baseline), and Visit 3 = stimulation visit, sham or active (about 1 week from visit 2)</time_frame>
    <description>Spontaneous oscillatory brain activity as measured by EEG using a wireless Enobio system (Neuroelectrics, Barcelona, Spain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attention Task</measure>
    <time_frame>Visit 2 and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Cognitive Performance (for attention) as measured by the Attention Network Task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>N Back test</measure>
    <time_frame>Visit 2 and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Cognitive Performance (for working memory) as measured by the</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to fatigue</measure>
    <time_frame>Visit 2 and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Time to fatigue as measured by total cycling time at 80% of peak power.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perception of physical exertion</measure>
    <time_frame>Visit 1, 2, and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Perception of physical exertion as measured by the 6-20 Borg Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Visit 1, 2, and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Heart rate as measured by a standard electrocardiogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>Visit 1, 2, and 3...where Visit 1 = baseline, Visit 2 = stimulation visit, randomly assigned sham or active (about 2 days from baseline), and Visit 3 = other stimulation visit, sham or active - one not received before (about 1 week from visit 2)</time_frame>
    <description>Respiratory rate as measured by a belt transducer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Healthy Participants</condition>
  <arm_group>
    <arm_group_label>active eMNS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with receive active eMNS for 20 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham eMNS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subjects with receive sham eMNS for 20 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active eMNS</intervention_name>
    <description>Each session will consist of right eMNS stimulation that will last 20-minutes. The frequency of stimulation will be random assigned using random frequency interval. The electrodes that will be used will be standard transcutaneous electrodes. The electrodes will be placed on the wrist.</description>
    <arm_group_label>active eMNS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham eMNS</intervention_name>
    <description>Each session of sham eMNS will be the same as active, except the device will be turned off. Similar parameters will be used (for 20 minutes and same electrode placement), except no stimulation will be delivered.</description>
    <arm_group_label>sham eMNS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to provide informed consent to participate in the study

          -  Able to perform physical activities such as cycling

          -  18-40 years old

          -  BMI&lt;27

          -  Practice of moderate intensity aerobic physical activity less than 150 minutes per
             week

        Exclusion Criteria:

          -  Hypertension

          -  Diabetes

          -  Cardiovascular disease

          -  Subjects with pacemakers, and/or implantable cardioverter-defibrillators

          -  History of asthma with active symptomatology in the past year, pulmonary disease or
             use of inhalers

          -  Physical disability, neurological and/or psychological disorder that precludes safe
             and adequate testing

          -  Conditions that may impair the ability to feel pain

          -  Mental impairment with limited ability to cooperate

          -  Uncorrected medical conditions, such as significant anemia, important electrolyte
             imbalance, or hyperthyroidism

          -  Pregnancy or trying to become pregnant in the next 6 months

          -  History of alcohol or drug abuse within the past 6 months as self-reported

          -  Epilepsy

          -  Suffering from severe depression (with a score &gt;30 in the Beck Depression Inventory)

          -  History of unexplained fainting spells as self-reported

          -  Head injury resulting in more than a momentary loss of consciousness

          -  History of neurosurgery as self-reported

          -  Use of antiepileptic and/or hypnotic medications like carbamazepine, valproate acid,
             gabapentin, zolpidem, etc.

          -  Use of medication with potential cardiovascular influence

          -  Active smoker, or history of smoking in the last 6 months

          -  Skin lesion or open wounds around or in area of electrode application

          -  Tattoos in upper limb or along the nerve tract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felipe Fregni, MD, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spaulding Rehabilitation Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spaulding Rehabilitation Network Research Institute</name>
      <address>
        <city>Charlestown</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2015</study_first_submitted>
  <study_first_submitted_qc>February 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2016</study_first_posted>
  <last_update_submitted>July 11, 2017</last_update_submitted>
  <last_update_submitted_qc>July 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spaulding Rehabilitation Hospital</investigator_affiliation>
    <investigator_full_name>Felipe Fregni</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

